
₹https://clinic.vasaneye.com/hospital-locator/hyderabad/gachibowli/vasan-eye-care-hospital-in-gachibowli-hyderabad--4Ymu3Q/articles/diabetic-retinopathy-icd-10-codes-classification-a--b274ba2e-dff8-4c01-8371-9d6168fe2cf7Accept terms & conditions, receive calls, notifications on WhatsApp
Hereby accept to send me newsletters for marketing and promotional content

Diabetes and the eye have a complex relationship. Over years, high blood sugar quietly damages the tiny blood vessels of the retina, and many patients develop diabetic retinopathy long before they notice any change in vision. In clinical practice, doctors, insurers, and public health systems rely on a standardised coding system, ICD-10, to describe the type and severity of diabetic retinopathy consistently.
For patients seeking retina care in Gachibowli, Hyderabad, understanding these codes can help make sense of diagnosis reports, treatment plans, and insurance documentation.
This guide walks you through the main ICD-10 codes for diabetic retinopathy, the classification system behind them, and why they matter for patients.
ICD-10 is the 10th revision of the International Classification of Diseases, used globally for recording medical diagnoses. It is maintained by the World Health Organization (WHO) and adapted locally. Each code captures specific details about a condition.
For diabetic retinopathy, ICD-10 codes record:
Type of diabetes (type 1, type 2, other specified, or unspecified)
Presence of retinopathy
Severity (mild, moderate, severe, proliferative)
Presence or absence of macular oedema
Laterality in some country-specific modifications
Diabetic retinopathy is damage to the retinal blood vessels caused by long-term high blood sugar. It has two broad stages:
Small aneurysms, haemorrhages, exudates, and cotton wool spots in the retina. Divided into mild, moderate, and severe.
New abnormal blood vessels grow on the retina and optic disc. These can bleed and cause tractional retinal detachment. It is a more advanced stage.
Swelling in the central retina (macula) that affects reading and fine vision. Can occur at any stage of diabetic retinopathy.
E10.3 — Type 1 diabetes mellitus with ophthalmic complications
E10.31 — With unspecified diabetic retinopathy
E10.32 — With mild NPDR
E10.33 — With moderate NPDR
E10.34 — With severe NPDR
E10.35 — With proliferative diabetic retinopathy
E10.36 — With diabetic cataract
E10.37 — With macular oedema
E10.39 — With other ophthalmic complications
E11.3 — Type 2 diabetes mellitus with ophthalmic complications
E11.31 — With unspecified diabetic retinopathy
E11.32 — With mild NPDR
E11.33 — With moderate NPDR
E11.34 — With severe NPDR
E11.35 — With proliferative diabetic retinopathy
E11.36 — With diabetic cataract
E11.37 — With macular oedema
E11.39 — With other ophthalmic complications
E13.3 — Other specified diabetes with ophthalmic complications (e.g., MODY, secondary diabetes)
E08.3 — Diabetes due to an underlying condition
E09.3 — Drug- or chemical-induced diabetes with ophthalmic complications
E11.40 — Type 2 diabetes with diabetic neuropathy, unspecified
E11.42 — Type 2 diabetes with diabetic polyneuropathy
H35.81 — Retinal oedema, independent of diabetes
Z79.4 — Long-term (current) use of insulin
Z79.84 — Long-term (current) use of oral hypoglycaemic drugs
Z13.5 — Screening for eye and ear disorders
Z86.39 — Personal history of other specified endocrine, nutritional and metabolic diseases
Z79.4 indicates long-term current use of insulin.
Z79.84 indicates long-term current use of oral hypoglycaemic (or non-insulin antidiabetic) drugs.
Both are status codes showing continuous medication use, used alongside diabetes diagnosis codes rather than instead of them. They do not describe the disease itself but help paint a complete clinical picture.
E11.40 is Type 2 diabetes with diabetic neuropathy, unspecified. Used when neuropathy is documented without further detail.
E11.42 is Type 2 diabetes with diabetic polyneuropathy. Used when a specific widespread nerve involvement is documented.
These are examples of how ICD-10 captures neuropathic complications of diabetes in detail.
Most clinicians follow the International Clinical Diabetic Retinopathy Severity Scale.
No retinal abnormalities.
Microaneurysms only.
More than just microaneurysms.
But less than severe NPDR.
20 or more intraretinal haemorrhages in each of four quadrants
Or definite venous beading in two or more quadrants
Or prominent intraretinal microvascular abnormalities (IRMA) in one or more quadrants
Neovascularisation
Vitreous or preretinal haemorrhage
Classified separately as:
None apparent
Present (often further divided into centre-involving and non-centre-involving)
Codes capture the severity and type, allowing clear communication between specialists.
Correct codes help claims process smoothly.
National diabetic retinopathy programmes rely on coded data.
Hospitals use coded data to track outcomes and improve care.
Codes support clear, dated clinical records.
Specific severity codes trigger specific follow-up intervals.
A typical pathway at an eye hospital:
Detailed medical history, including type and duration of diabetes
Visual acuity testing
Dilated fundus examination
Fundus photography
OCT of the macula
Fluorescein angiography in selected cases
Severity grading using the international scale
Assignment of ICD-10 codes
Treatment plan based on severity
Tight diabetic control
Regular follow-up every 6–12 months
Blood pressure and cholesterol management
Counselling and lifestyle advice
Tight diabetic control
More frequent follow-up
Close monitoring for progression
Possibly anti-VEGF injections if macular oedema is present
Pan-retinal laser photocoagulation
Anti-VEGF injections
Vitrectomy in complicated cases
Urgent specialist referral
Anti-VEGF injections
Focal laser
Steroid implants in selected cases
Systemic control remains essential
Supportive eye treatments such as lubricating drops, cataract co-management, and vision rehabilitation complement specialist care. Vasan’s retinal team often combines specialist input with broader retinal disease treatment pathways.
Tight HbA1c control
Blood pressure control
Cholesterol management
Regular dilated eye examinations
Stopping smoking
Weight management
Physical activity
Balanced diet
Book an appointment if:
You have diabetes and have not had an eye check in a year
You notice blurred vision or new floaters
You have been told your diabetic retinopathy is changing
You see a sudden shower of floaters or flashes
A dark curtain or shadow appears in your vision
You are newly diagnosed with diabetes
You are pregnant with pre-existing diabetes
Urgent review is recommended for any sudden drop in vision.
Vasan Eye Care has been looking after patients across India since 2002, now as part of ASG Enterprises. With more than 150 super-speciality centres, 500+ ophthalmologists, and over 5,000 trained eye care staff, the team handles diabetic retinopathy daily with detailed examination, OCT, fundus photography, fluorescein angiography, laser therapy, intravitreal injections, and vitreoretinal surgery as required.
An eye specialist hospital in Gachibowli, Hyderabad can help patients receive coordinated care for diabetes-related eye conditions.
ICD-10 codes for diabetic retinopathy capture type of diabetes, severity, and macular oedema.
E10 codes are for type 1 diabetes, E11 codes for type 2, and E13 codes for other specified types.
Severity is graded as mild, moderate, severe NPDR, and PDR, with macular oedema coded separately.
Z79.4 and Z79.84 record insulin and oral antidiabetic drug use.
Correct coding supports treatment, follow-up, insurance, and research.
Tight diabetic control and regular eye checks remain the cornerstone of prevention.
Understanding Diabetic Retinopathy ICD-10 Codes helps patients, healthcare providers, and insurers communicate more accurately about diagnosis and treatment. For individuals in Gachibowli, Hyderabad, awareness of diabetic eye disease, proper classification, and timely retinal examinations can support better long-term vision outcomes. Regular monitoring, early diagnosis, and expert retinal care remain essential for preventing diabetes-related vision loss.